February, 2026

Comments on February 2026 Senate Economics Legislation Committee discussion on R&D Tax Incentive

February 13th, 2026

As reported in the media this week, the Senate Economics Legislation Committee discussed the administration of the R&D Tax Incentive. Swanson Reed has reviewed the discussion in detail. It involved interactions between three people, whose comments are summarised and paraphrased below: Greens Senator Barbara Pocock: Had queries around how many reviews are conducted each year; Queried whether staff conducting reviews include personnel with Science and Engineering qualifications; Asked for details of fines or penalties for incorrect claims, and indicated concerns that possible penalties […]

Read More

Significant Refundable R&D Offsets receipts reported to the ASX in recent months to January 2026

January 19th, 2026

Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $5.34 M related to its anti-infective platform; Race Oncology (ASX:RAC) received $2.8M related to its cancer treatments; Ecograf (ASX: EGR) received $1.7M related to its EcoGraf HFfree proprietary purification technology; Chimeric Therapeutics (ASX: CHM)  received $4.5M related to its cancer treatments; Elixir Energy (ASX: EXR) received $3.8M related to its unconventional gas project […]

Read More

R&D Tax Incentive – Potential Key Events in 2026

January 7th, 2026

Some key events impacting Australia’s R&D Tax Incentive over the past 12 months during calendar year 2025 included: The release of proposed legislation to exclude gambling and tobacco companies from eligibility under the R&D Tax Incentive; The strategic examination and review of Australia’s Research and Development (R&D) system progressed and released a discussion paper on R&D Incentives that contained some significant potential changes for consideration. Swanson Reed made a submission to both the general review and the discussion paper on R&D Incentives; A new R&D Tax Incentive registration […]

Read More

2025 Annual Report for IISA: Update on R&D Tax Legal matters and litigation

December 5th, 2025

Industry Innovation and Science Australia (IISA) is the federal government department responsible for determining whether companies’ activities meet the legislative criteria eligible under the R&D Tax Incentive.  The 2025 Annual Report for IISA was recently released, and a section of the report provides an update on Legal matters and litigation relevant to the department. Litigation on R&D activity now usually starts in the The Administrative Review Tribunal of Australia (ART), rather than Administrative Appeals Tribunal (AAT). However, this change is not likely […]

Read More

Categories

Archives